|
|
The NEURAPRO (North America, EURope, Australia PROdrome) Study: A multicenter RCT of Treatment Strategies for Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders (Amount actually received ca. 150'00
| Third-party funded project |
| Project title |
The NEURAPRO (North America, EURope, Australia PROdrome) Study: A multicenter RCT of Treatment Strategies for Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders (Amount actually received ca. 150'000 US$ - umger. 2009 in CHF ca. 175'000 CHF) |
| Principal Investigator(s) |
Riecher-Rössler, Anita
|
| Co-Investigator(s) |
Riecher-Rössler, Anita
|
| Organisation / Research unit |
Bereich Psychiatrie (Klinik) / Erwachsenenpsychiatrie (Riecher-Rössler) |
| Project start |
01.01.2008 |
| Probable end |
31.12.2013 |
| Status |
Completed |
| Abstract |
The NEURAPRO-E study (North America, EUR, Australia PROdrome Study) aims to assess the effect of omega-3 fatty acid treatment combined with a cognitive behavioural therapy and case management program on the conversion to psychosis in symptomatic young people at ultra high risk of developing a psychotic illness, as compared to the effect of cognitive behavioural therapy and case management alone. The primary outcome to be measured is the rate of transition to psychosis at 6 months, as determined by the Comprehensive Assessment of At-Risk Mental States instrument (CAARMS). Secondary outcomes will include assessment of the levels of symptomatology, including depression, positive, negative and basic symptoms, and levels of social, occupational, and general functioning, as well as assessment of the rate of transition to psychosis at 12 and 24 months of follow-up. |
| Financed by |
Foundations and Associations
|
| |
|
|
MCSS v5.8 PRO. 0.430 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
20/04/2024
Research Database / FORSCHUNGSDATENBANK
|
